PFIZER INC. DL-,05 (PFE.DE) Financials
PFE.DE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 226.5 billion | 137.2 billion |
| 2023-09-30 | 215.0 billion | 117.8 billion |
| 2023-06-30 | 220.2 billion | 120.9 billion |
| 2023-03-31 | 195.6 billion | 94.4 billion |
PFE.DE Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 4.2 billion | 121.0 million |
| 2023-09-30 | 2.6 billion | 151.0 million |
| 2023-06-30 | -2.1 billion | 148.0 million |
| 2023-03-31 | 73.0 million | 105.0 million |
PFE.DE Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | -3.3 billion |
| 2023-09-30 | -2.4 billion |
| 2023-06-30 | 2.3 billion |
| 2023-03-31 | 5.6 billion |
PFE.DE Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 12.7 billion | - | - |
| 2023-09-30 | 44.2 billion | - | - |
| 2023-06-30 | 44.8 billion | - | - |
| 2023-03-31 | 20.0 billion | - | - |
PFE.DE Shares Outstanding
PFE.DE Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 1.0 billion | 2.7 billion | 414.0 million | 3.7 billion |
| 2023-09-30 | 810.0 million | 2.7 billion | 3.3 billion | - |
| 2023-06-30 | 914.0 million | 2.6 billion | 3.5 billion | - |
| 2023-03-31 | 1.1 billion | 2.5 billion | 3.4 billion | - |
PFE.DE Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 14.2 billion | 13.1 billion |
| 2023-09-30 | 13.2 billion | 9.3 billion |
| 2023-06-30 | 12.7 billion | 3.2 billion |
| 2023-03-31 | 18.3 billion | 4.9 billion |
PFE.DE
Price: €23.78
Dividend Yield: 0.07%
Forward Dividend Yield: 7.06%
Payout Ratio: 494.12%
Dividend Per Share: 1.68 EUR
Earnings Per Share: 0.35 EUR
P/E Ratio: 75.29
Exchange: GER
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 22820
Market Capitalization: 137.9 billion
Average Dividend Frequency: 4
Years Paying Dividends: 25
DGR3: 3.32%
DGR5: 7.15%
DGR10: 6.10%
DGR20: 13.43%